CanPursue

Research

  • Search
  • Opportunities
  • Buyers
  • Suppliers
  • Contracts
  • Awards

Intelligence

  • OverviewAccount required
  • WatchlistsAccount required
  • PipelineAccount required
  • IntelligenceAccount required
Create free account

Sign in

⌘K
ENFR
ACQUISITION DU KYMRIAH - TISAGENLECLEUCEL (THERAPIE CELLULAIRE)- PHARMACIE | Government award · CanPursue
Awards

ACQUISITION DU KYMRIAH - TISAGENLECLEUCEL (THERAPIE CELLULAIRE)- PHARMACIE

20009260$22.5M
Buyer
CHU Ste-Justine
Supplier
Novartis Pharma Canada inc.
Value
$22.5M
Award date
Sep 10, 2024
Status
active
Source
SEAO
20009260
Related procurement
View full record